Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Mr. Vincent  Brancaccio

Head of Human Resources

Mr. Jorge  Velarde Jr., MBA

Chief Business Officer

Dr. Jyotsna  Ghai Ph.D.

Chief Operating Officer

Mr. Jeff  Bullard

Head of Sales

Mr. Eric  Stier

Senior Vice President, General Counsel & Secretary

Mr. Andrew  Spaventa

Founder, Chief Executive Officer, President & Chairperson of the Board

Dr. David L. Barker Ph.D.

Founder, Member of Scientific Advisory Board & Independent Director

Dr. Eli N. Glezer Ph.D.

Founder, Chief Scientific Officer & Chair of Scientific Advisory Board

Mr. Dalen  Meeter

Chief Financial Officer

Pavadinimas	Rinkos kapitalizacija
ConvaTec Group Plc	0M
Jiangsu Apon Medical Technology Co., Ltd.	0M
Bausch + Lomb Corporation	0M
SD BioSensor, Inc	0M
Ypsomed Holding AG	0M
InfuSystem Holdings, Inc.	0M
Sansure Biotech Inc.	0M
Menicon Co., Ltd.	0M
Alcon Inc.	0M
Nipro Corporation	0M
OrbusNeich Medical Group Holdings Limited	0M

Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc. Konkurentų sąrašas

Pagrindiniai konkurentai